GUESS? INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Guess?, Inc.
If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nyse-ges/ to learn more.
To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
3 minutes ago
- Business Wire
Power and Portability Meet Toughness. New Use Energy Unveils the Revolutionary 605 SunCase™: Ultra-Portable Power at Just 16 lbs.
ANACORTES, Wash.--(BUSINESS WIRE)--In direct response to requests from various Special Forces, Military Medical, Drone, and Counter Drone units, New Use Energy Solutions, Inc. (NUE), a leading innovator in ruggedized mobile solar-plus-battery generator systems, today announced the highly anticipated launch of its 605 SunCase™. At an astonishingly light 16 pounds, the 605 SunCase™ is a groundbreaking portable power solution. It's designed for unparalleled mobility and silent operation, delivering robust, reliable power in the toughest conditions. The 605 SunCase™ redefines what's possible in portable power, packing a powerful 550Wh LiFePO4 battery and a 600W pure sine wave inverter into a compact, weather-resistant, fire-retardant, thermoplastic case. Its featherlight design and grab-and-go portability make it an indispensable tool where traditional, heavy, and noisy generators are impractical or prohibited and consumer grade units just don't take the beating. "The 605 SunCase™ is a testament to our commitment to innovation and understanding the critical needs of our users," said Paul Shmotolohka, CEO of New Use Energy. "We've engineered a solution that delivers power without the weight, noise, or heat signature of conventional generators. This unit empowers professionals across diverse fields—from military personnel to cinematographers in remote location to operate with unprecedented freedom and efficiency, ultimately enhancing their capabilities and ensuring mission success." Key Features and Impact of the 605 SunCase™: Ultra-Portable at 16 lbs (7 kg): Its light weight allows for easy transport and deployment in challenging terrains, tight spaces, or rapid-response scenarios, expanding operational possibilities. Silent, Fuel-Free Operation: Unlike gas generators, the 605 SunCase™ operates silently with no emissions or heat signature, making it ideal for stealth operations in electronic warfare, quiet film sets, or indoor use. Rugged & Reliable: Encased in a tough, weather-resistant shell (conforming to IP55), it's built to withstand major shocks, drops, and extreme temperatures, drawing on NUE's proven durability in demanding environments, including war zones. Empowering the Creative: For film and TV production, the 605 SunCase™ liberates lighting and camera crews from the constraints of "bandit cable" and centralized generators for basic equipment charging such as cameras and monitors. Critical Military & Emergency Support: Building on NUE's success in powering over 40 brigades in the US and Ukraine, the 605 SunCase™ is perfectly suited for powering sensitive equipment for drone teams (signal boosters, goggles, monitors), dismounted battlefield intelligence, and critical medical devices (IV pumps, ventilators) where uninterrupted power is non-negotiable. Its rapid 20-millisecond transfer time ensures seamless operation during power fluctuations. Versatile Charging: The 605 SunCase™ features multiple output options (AC, USB-A, USB-C, 12V DC) and can be rapidly recharged via solar (built-in 400W MPPT controller), AC, or vehicle alternators. The launch of the 605 SunCase™ reinforces New Use Energy's commitment to providing cutting-edge, environmentally conscious power solutions that enhance user experience and operational outcomes. It's not just a power station; it's a force multiplier for those who demand the best in portable energy. The new 605 SunCase™ is available for purchase starting September 2025 through New Use Energy's website and authorized dealers. About New Use Energy New Use Energy Solutions, Inc. is an American company leading the development and distribution of proprietary, state-of-the-art, ruggedized mobile solar-plus-battery generator systems. Engineered for the most demanding commercial, industrial, and government applications, NUE delivers clean, renewable, and reliable power wherever it is needed. With a proven track record in military, emergency response, and humanitarian aid, NUE is committed to creating a new generation of energy sources that respond to the challenges of modern times, empowering professionals, communities, and the planet.
Business Wire
33 minutes ago
- Business Wire
Acorn Health Names Mony Iyer CEO
CORAL GABLES, Fla.--(BUSINESS WIRE)--Acorn Health, a leading national provider of applied behavior analysis (ABA) therapy for children diagnosed with autism spectrum disorder (ASD), announces Mony Iyer as its new president and chief executive officer, effective Sept. 15, 2025. What drew me to Acorn Health is its clear mission and strong culture of care. Over the course of my career, I have experienced how empowering teams and clinicians leads to better outcomes for those we serve. Share 'We are delighted to welcome Mony to Acorn Health,' said Imran Siddiqui, a member of Acorn Health's board of directors and managing director of Ontario Teachers' Pension Plan. 'A nationally recognized business leader, he brings the unique combination of championing culture and inspiring teams while scaling organizations with purpose. We are excited to support him as he leads Acorn Health into its next stage of growth and impact.' Iyer has more than 20 years of experience leading large, mission-driven organizations. Most recently, he served as president of Banfield Pet Hospital, one of the largest veterinary companies in the US. Prior to that he was vice president of specialty healthcare services for Walmart, president of OneSight and vice president for Luxottica Group. 'What drew me to Acorn Health is its clear mission and strong culture of care,' said Iyer. 'Over the course of my career, I have experienced how empowering teams and clinicians leads to better outcomes for those we serve. I am eager to build on that foundation by investing in and strengthening our teams that provide such critical care to our clients, expanding access for families, and ensuring that Acorn continues to grow in a way that reflects its values.' Iyer holds a bachelor's degree in electronics and communication engineering from The University of Madras, a master's degree in electrical engineering, and an MBA from Duke University. Rich Hallworth, who has led Acorn Health since 2023, will retire from the CEO role and continue to serve as an active member of Acorn Health's board of directors. 'It has been a privilege to lead Acorn Health and to work alongside such a talented team,' Hallworth said. 'As I transition into retirement, I am pleased to remain an active member of the board and continue supporting the organization's mission. I have full confidence in Mony's leadership and in the team's ability to carry Acorn forward.' About Acorn Health: Acorn Health is accredited by the Autism Commission on Quality and offers both center-based and in-home services nationwide in more than 70 centers located throughout Florida, Illinois, Maryland, Michigan, Pennsylvania, Tennessee, and Virginia. Founded in 2018, Acorn is committed to providing industry-leading quality clinical care through applied behavioral analysis (ABA) therapy to give children diagnosed with autism spectrum disorder (ASD) the opportunity to live more independent and meaningful lives. Cases of ASD are on the rise; according to the Centers for Disease Control and Prevention, one in 31 children is living with ASD. ABA therapy, a program endorsed by the U.S. Surgeon General, provides individualized plans for each patient based on agreed upon clear, measurable goals with the child's family. Acorn Health uses its proprietary Behavioral Health Index to measure success in ways that are easily understood by families, clinicians and educators. To learn more about Acorn Health, visit and to learn about career opportunities, visit . To inquire about ABA therapy at Acorn Health, please call 844.244.1818.
Yahoo
an hour ago
- Yahoo
3 Dow Jones Dividend Stocks With Above-Average Yields You Can Buy Now and Hold for at Least a Decade
Key Points UnitedHealth Group's reduced profit forecast for 2025 is disappointing, but the health insurance business is in a good position to bounce back. Coca-Cola's dividend payout has risen for 63 consecutive years. Amgen sells over a dozen drugs that are growing sales at a double-digit annual percentage. 10 stocks we like better than UnitedHealth Group › Income-seeking investors who value their time know the best dividend stocks don't need a lot of babysitting. Some go on decades-long payout-raising streaks. The Dow Jones Industrial Average (DJINDICES: ^DJI) is one of the best places to find reliable dividend payers. Stocks aren't added to this exclusive list unless they have already demonstrated an ability to produce profits in good economic times and bad ones, too. The average dividend payer in the Dow Jones Industrial Average offers a measly 1.6% yield at recent prices. UnitedHealth Group (NYSE: UNH), Coca-Cola (NYSE: KO), and Amgen (NASDAQ: AMGN) stand out with above-average yields. Here's why they could be great additions to a long-term dividend investor's portfolio. 1. UnitedHealth Group Shares of UnitedHealth Group collapsed in May, after the company simultaneously suspended its 2025 outlook and announced an abrupt CEO exit. To top it off, the company felt it was necessary to issue responses to several Wall Street Journal articles and a Department of Justice investigation regarding its Medicare business. The stock is down, but its dividend payout is way up. The company raised it by 76.8% over the past five years. At its beaten-down price, the stock offers a 2.7% yield. Health insurance businesses operate on thin margins. It turns out that UnitedHealth mispriced premiums going into 2025. Healthcare providers are charging more than the company anticipated, plus the amount of care new members have been using is also higher than expected. Smart investors such as Warren Buffett know that UnitedHealth Group is mostly a middleman that can pass increased costs on to health plan sponsors. It may have mispriced premiums going into 2025, but this isn't a mistake its recently refreshed management team is likely to make again in the decade ahead. 2. Coca-Cola Unlike UnitedHealth, Coca-Cola stock is up near its all-time high. The soda giant's dividend hasn't risen as sharply as the health insurer's, but it's still up by 24.4% over the past five years. Being the only company that can sell many of the world's most popular beverage brands is a strong advantage that leads to consistent profits. In February, the company announced a dividend raise for the 63rd year in a row. Shares of Coca-Cola offer a 2.9% yield at recent prices, and another decade of significant dividend raises isn't an unreasonable expectation. Second-quarter unit case volume fell by 1%, but the strength of its brands allowed organic revenue to rise by 5% year over year. Sales of sugary sodas have been losing ground to sports drinks, but the company has this base covered. Its BodyArmor brand boasts a double-digit share of the U.S. market, and its older Powerade brand is even more popular. Adding some shares of this stock to a diverse portfolio is an almost certain way to boost your passive income stream over time. 3. Amgen Shares of biotechnology pioneer Amgen have been trading about 12% below the all-time high they set last year. Amgen began paying a dividend in 2011 and has been able to increase it every year since. The drugmaker raised its payout by 48.8% over the past five years. At recent prices, it offers a 3.2% yield. Two of Amgen's top revenue streams, Enbrel and Prolia, are drying up thanks to biosimilar competition. Fortunately, the losses are easily offset by a slew of more recently launched products. Amgen recently reported year-over-year sales increases at a double-digit percentage for 15 products in the second quarter. New competition for Enbrel and Prolia limited second-quarter sales growth to 9% year over year. Enbrel and Prolia losses will most likely reach a bottom long before Amgen's new growth drivers run out of fuel. With a strong lineup of new products, this company could report strong sales growth in the decade ahead. Should you buy stock in UnitedHealth Group right now? Before you buy stock in UnitedHealth Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and UnitedHealth Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $671,466!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,115,633!* Now, it's worth noting Stock Advisor's total average return is 1,077% — a market-crushing outperformance compared to 185% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 18, 2025 Cory Renauer has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Amgen. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy. 3 Dow Jones Dividend Stocks With Above-Average Yields You Can Buy Now and Hold for at Least a Decade was originally published by The Motley Fool
